Co-Authors
This is a "connection" page, showing publications co-authored by Hendrik Schulze-Koops and Christof Specker.
Connection Strength
3.958
-
No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al. Ann Rheum Dis. 2020 May 31.
Score: 0.885
-
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. Z Rheumatol. 2021 Sep; 80(7):641-646.
Score: 0.238
-
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information. Rheumatology (Oxford). 2021 05 14; 60(5):2128-2133.
Score: 0.236
-
[Annual meeting of the German Society for Rheumatology going virtual-successfully defying the pandemic]. Z Rheumatol. 2021 Jun; 80(5):399-407.
Score: 0.235
-
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open. 2021 02; 7(1).
Score: 0.232
-
[Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients]. Z Rheumatol. 2021 02; 80(1):43-44.
Score: 0.231
-
Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'. Ann Rheum Dis. 2020 Oct 30.
Score: 0.228
-
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open. 2020 09; 6(2).
Score: 0.225
-
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]. Z Rheumatol. 2020 Sep; 79(7):679-685.
Score: 0.225
-
Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: 'Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak' by So et al. Ann Rheum Dis. 2020 Jun 24.
Score: 0.222
-
Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al. Ann Rheum Dis. 2020 Jun 23.
Score: 0.222
-
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic]. Z Rheumatol. 2020 May; 79(4):385-388.
Score: 0.220
-
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Ann Rheum Dis. 2020 06; 79(6):840-842.
Score: 0.220
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.059
-
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis? Clin Exp Rheumatol. 2021 May-Jun; 39(3):639-647.
Score: 0.059
-
[Current state of vaccination against SARS-CoV-2]. Z Rheumatol. 2021 Mar; 80(2):158-164.
Score: 0.058
-
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open. 2021 01; 7(1).
Score: 0.058
-
[SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments]. Z Rheumatol. 2020 Sep; 79(7):686-691.
Score: 0.056
-
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]. Z Rheumatol. 2018 Aug; 77(Suppl 2):35-53.
Score: 0.049